JP2012021008A5 - - Google Patents

Download PDF

Info

Publication number
JP2012021008A5
JP2012021008A5 JP2011179648A JP2011179648A JP2012021008A5 JP 2012021008 A5 JP2012021008 A5 JP 2012021008A5 JP 2011179648 A JP2011179648 A JP 2011179648A JP 2011179648 A JP2011179648 A JP 2011179648A JP 2012021008 A5 JP2012021008 A5 JP 2012021008A5
Authority
JP
Japan
Prior art keywords
microparticles
less
pharmaceutical composition
enteric coating
acid labile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011179648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012021008A (ja
Filing date
Publication date
Priority claimed from US10/190,242 external-priority patent/US20040005362A1/en
Application filed filed Critical
Publication of JP2012021008A publication Critical patent/JP2012021008A/ja
Publication of JP2012021008A5 publication Critical patent/JP2012021008A5/ja
Withdrawn legal-status Critical Current

Links

JP2011179648A 2002-07-03 2011-08-19 酸不安定性薬物の液体剤形 Withdrawn JP2012021008A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/190,242 2002-07-03
US10/190,242 US20040005362A1 (en) 2002-07-03 2002-07-03 Liquid dosage forms of acid labile drugs

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004519788A Division JP2005533832A (ja) 2002-07-03 2003-07-02 酸不安定性薬物の液体剤形

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015021882A Division JP5997788B2 (ja) 2002-07-03 2015-02-06 酸不安定性薬物の液体剤形

Publications (2)

Publication Number Publication Date
JP2012021008A JP2012021008A (ja) 2012-02-02
JP2012021008A5 true JP2012021008A5 (enExample) 2012-08-02

Family

ID=29999830

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2004519788A Pending JP2005533832A (ja) 2002-07-03 2003-07-02 酸不安定性薬物の液体剤形
JP2011179648A Withdrawn JP2012021008A (ja) 2002-07-03 2011-08-19 酸不安定性薬物の液体剤形
JP2015021882A Expired - Fee Related JP5997788B2 (ja) 2002-07-03 2015-02-06 酸不安定性薬物の液体剤形
JP2016049674A Expired - Fee Related JP6209237B2 (ja) 2002-07-03 2016-03-14 酸不安定性薬物の液体剤形
JP2017115697A Pending JP2017206525A (ja) 2002-07-03 2017-06-13 酸不安定性薬物の液体剤形

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004519788A Pending JP2005533832A (ja) 2002-07-03 2003-07-02 酸不安定性薬物の液体剤形

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015021882A Expired - Fee Related JP5997788B2 (ja) 2002-07-03 2015-02-06 酸不安定性薬物の液体剤形
JP2016049674A Expired - Fee Related JP6209237B2 (ja) 2002-07-03 2016-03-14 酸不安定性薬物の液体剤形
JP2017115697A Pending JP2017206525A (ja) 2002-07-03 2017-06-13 酸不安定性薬物の液体剤形

Country Status (7)

Country Link
US (1) US20040005362A1 (enExample)
EP (1) EP1539156B8 (enExample)
JP (5) JP2005533832A (enExample)
CA (1) CA2490145C (enExample)
ES (1) ES2401102T3 (enExample)
MX (1) MXPA05000298A (enExample)
WO (1) WO2004004718A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
AU2004257864A1 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
EP1718303A4 (en) * 2004-02-10 2010-09-01 Santarus Inc COMBINATION OF INHIBITOR OF PROTON PUMP, BUFFER AND NON-STEROIDAL ANTI-INFLAMMATORY DRUG
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
HUE051635T2 (hu) * 2013-12-12 2021-03-01 Hollister Inc Toalettben lehúzható szétmálló katéter
JP6122815B2 (ja) * 2014-02-20 2017-04-26 ライオン株式会社 経口製剤及びその製造方法
BE1024339B1 (fr) * 2016-07-01 2018-01-29 Be Pharbel Mfg Sa Microparticules multicouches libérant un composé pharmaceutiquement actif dans une forme pharmaceutique liquide
US12472149B2 (en) 2015-07-17 2025-11-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
CN108348475B (zh) * 2015-07-17 2022-01-04 比利时法贝尔制造股份有限公司 处于液体剂型的多层药学活性化合物释放微粒
EP3117824A1 (en) * 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
JPH06319496A (ja) * 1993-05-11 1994-11-22 Seiichi Kudo リンゴジュース
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
JP4939680B2 (ja) * 1997-05-27 2012-05-30 武田薬品工業株式会社 固形製剤
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
CA2318087A1 (en) * 1998-01-30 1999-08-05 Errol V. Raghubeer Method for ultra high pressure inactivation of microorganisms in juice products
PT1121103E (pt) * 1998-05-18 2007-02-28 Takeda Pharmaceutical Comprimidos de desintegração oral compreendendo um benzimidazole
EE200100660A (et) * 1999-06-07 2003-04-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Ravimvorm happe suhtes labiilsete toimeainete jaoks, toimeaine üksus, selle valmistamismeetod ja mikrokerake
JP5009482B2 (ja) * 2000-12-07 2012-08-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸に不安定な活性成分を含有する懸濁液の形の製薬製剤

Similar Documents

Publication Publication Date Title
HUS2100018I1 (hu) Hatóanyagok légúti beadására alkalmas készítmények és ezekkel kapcsolatos eljárások
JP2016513069A5 (enExample)
JP2011126892A5 (enExample)
BRPI0915411A2 (pt) partículas revestidas contendo agentes farmaceuticamente ativos
JP2011511805A5 (enExample)
JP2012126725A5 (enExample)
PL2790681T3 (pl) Sposób otrzymywania kompozycji farmaceutycznej o przedłużonym uwalnianiu zawierającej mikrocząstki białkowe powlekane polimerem z wykorzystaniem suszenia rozpyłowego
EP2658527A4 (en) NANOPARTICLES AND SURFACE-MODIFIED PARTICLE COATINGS, COATED BALLOONS AND METHOD THEREFOR
JP2013523703A5 (enExample)
JP2015504870A5 (enExample)
JP2019515674A5 (enExample)
JP2016533322A5 (enExample)
JP2011256183A5 (enExample)
EP2019665A4 (en) DRUG DISPERSION OF CAPSULES COVERED WITH NANOTEILS
EP2726975A4 (en) ACTIVATION PROCEDURE FOR A STORAGE GATEWAY
JP2014513036A5 (enExample)
JP2015501646A5 (enExample)
PL2230932T3 (pl) Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym
JP2016510130A5 (enExample)
EP2760433A4 (en) PH-DEPENDENT SUPPORTS FOR THE TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINALTRAKTS, COMPOSITIONS, AND THEIR PREPARATION AND USE
JP2013540702A5 (enExample)
JP2011137005A5 (enExample)
IL206450A0 (en) Use of an acetylsalicylic acid salt for the treatment of viral infections
JP2013508091A5 (enExample)
HRP20191348T1 (hr) Aminosteroidi za liječenje bolesti povezanih s ptp1b